A carregar...

The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer

In addition to the direct targeting effects on HER2-positive cells, trastuzumab may have a therapeutic role modulating the activity of the cellular immune system in patients with breast cancer. To investigate this further, the balance of T-regulatory (T(reg)), Th17, natural killer (NK) and NK T (NKT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Horlock, C, Stott, B, Dyson, P J, Morishita, M, Coombes, R C, Savage, P, Stebbing, J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670001/
https://ncbi.nlm.nih.gov/pubmed/19277040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604963
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!